C21H22BrFN4O2
Neat
461.34
+5°C
Room Temperature
N-Desmethyl vandetanib; 338992-12-4; N-Desmethylvandetanib; N-Desmethyl-ZD6474; K4I43R5TNP; N-Desmethyl metabolite of vandetanib; J1.720.299E; M382558; 4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-((piperidin-4-yl)methoxy)quinazoline; 4-Quinazolinamine, N-(4-bromo-2-fluorophenyl)-6-methoxy-7-(4-piperidinylmethoxy)-; RefChem:1091714; N-Demethyl Vandetanib; N-(4-bromo-2-fluorophenyl)-6-methoxy-7-(piperidin-4-ylmethoxy)quinazolin-4-amine; UNII-K4I43R5TNP; N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(piperidin-4-yl)methoxy]quinazolin-4-amine; 4-Anilinoquinazoline 22; 4-Quinazolinamine and N-(4-bromo-2-fluorophenyl)-6-methoxy-7-(4-piperidinylmethoxy)-; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-(4-piperidinylmethoxy)-4-quinazolinamine; 4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[(piperidin-4-yl)methoxy]quinazoline; N-Demethyl Va; C21H22BrFN4O2; BDBM4675; SCHEMBL1612820
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-(piperidin-4-ylmethoxy)quinazolin-4-amine
InChI=1S/C21H22BrFN4O2/c1-28-19-9-15-18(10-20(19)29-11-13-4-6-24-7-5-13)25-12-26-21(15)27-17-3-2-14(22)8-16(17)23/h2-3,8-10,12-13,24H,4-7,11H2,1H3,(H,25,26,27)